Methods of synthesis, structure and biological activity of 5-nitro-9-N-arylaminoacridines
DOI:
https://doi.org/10.24959/ophcj.14.805Keywords:
synthesis, 5-nitro-9-N-arylaminoacridines, pharmacological activityAbstract
With the purpose of search of new biologically active substances the synthesis of nine derivatives of 5-nitro-9-Narylaminoacridinium (2a-i) has been carried out by interaction of the corresponding 5-nitro-9-chloracridines and aromatic amines in two ways: in the phenol medium (method A) and in the dioxane medium in the presence of hydrochloric acid (method B). It has been experimentally proven that method B is more expedient because it is characterized by the absence of toxic phenol in the synthesis, reduction of the experiment time, a high yield of the desired product (87-94%). The structure and individuality of compounds synthesized that are undescribed in the literature have been confirmed by IR-, NMR-spectral and chromatographic analysis. The choice of the pharmacological screening spectrum has been conducted using data of PASS-prognosis, scientific and patent literature. It has been found experimentally that the substances synthesized possess a moderate bacteriostatic and fungistatic, expressed anti-inflammatory and analgesic, high diuretic (compounds 2d-f) and antidiuretic (compounds 2h-i) activities. According to the classification by K.K.Sydorov the compounds synthesized when introduced intragastrically belong to low toxic compounds. Some regularities of the “structure – biological activity – toxicity” dependence have been analyzed, and it is an important element in determining the areas for further research to develop new biologically active substances.
Downloads
References
- Volyanskiy Yu. L., Krestetska S. L. Visn. nauk. doslidzhen – Journal of scientific research, 2002, No.4, pp.5-8. 1. Ershov F. I., Kiselev V. I., Kiselev O. I. Vestnik Rossiyskoy Akademii med. nauk – Bulletin of the Russian Academy of med. sciences, 2004, No.2, pp.29-34.
- Gregory D. Cuny, Maxime Robin, Natalia P. Ulyanova, Debasis Patnaik, Valerie Pique, Gilles Casano, Ji-Feng Liu, Xiangjie Lin, Jun Xian, Marcie A. Glicksman, Ross L. Stein, Jonathan M. G. Higgins. Bioorg. & Med. Chem. Letters, 2010, Vol. 20, Is. 12. pp.3491-4394.
- Malachowska-Ugartea M., Cholewinskia G., Dzierzbickaa K., Trzonkowskib P. Eur. J. Med. Chem., 2012, Vol. 54, No.8, pp.197-201.
- Tlegenov R. T. Him.-farmats. zhurn. – Chem.-pharm. Journal, 2008, Vol. 42, No.10, pp.27-28.
- Stefanov O. V. Doklinichni doslidzhennya likarskih zasobiv: metod. rekomendatsiyi (Preclinical studies of drugs: methodical recommendations). Kiyiv: Avitsenna, 2001, 528 p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
